See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.24▲ 0.77%
← AMS2 page
XStocksXray
Market X-Ray report · 22 October 2026

AMS OSRAM AG (AMS2)

Vienna Exchange · Austria · prices in EUR · close of 22 Oct 2026

Key indicators

Last closeEUR 19.35
52-week range7.25 – 27.70
Return, 1 month / 3 months−14.0% / +4.6%
Return, 1 year / 3 years+45.7% / −4.1%
TrendAbove 200-day, below 50-day
RSI (14)42
Volatility (1 year)84.0%
Worst drawdown (1 year)-40.6%
Average daily value traded0.16M EUR
Dividend yield–

Market X-Ray price-based

57/ 100 · High confidence · ahead of 61% of stocks on this exchange
Trend70
Momentum83
Stability (higher is calmer)13
Liquidity64
Income–

Five-year price chart navy: price · brown: 200-day average

0.2124.9149.6274.3399.032021-112023-022024-052025-072026-10

About the company

ams OSRAM is a sensor and lighting technology company formed from the combination of ams and Osram. It designs and makes optical sensors, light-emitting diodes, laser components and related modules. Its customers are manufacturers in the automotive, industrial, medical and consumer electronics markets, who use these parts in vehicles, lighting systems, mobile devices and sensing applications. The company is based in Austria and Germany and supplies customers around the world.

The shares are listed on the Vienna Exchange in Austria under the code AMS2, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

AMS OSRAM AG (AMS2) trades on the Vienna Exchange in Austria. It last closed at EUR 19.35 on 22 October 2026.

Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 33 of 84 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 45.7% and over the last three months it rose 4.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
AMS OSRAM AG (AMS2)

The five lenses in numbers each metric is ranked against the other stocks on Vienna Exchange

Lens and metricValueScoreReading
Trend70 · StrongTrading above its long-term averages and near its highs.
Above 200-day average19.7%
From 52-week high-28.3%
Momentum83 · StrongRising faster than most stocks on this exchange.
3-month return4.6%
6-month return40.7%
12-month return, skipping the last month69.4%
Stability (higher is calmer)13 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)84.0%
Worst drawdown, 1 year (smaller is calmer)-40.6%
Liquidity64 · FairModerate trading activity.
Average daily value traded0.16M EUR
Zero-volume days1.7%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+1.3%
1 month−14.0%
3 months+4.6%
6 months+40.7%
1 year+45.7%
3 years−4.1%
5 years−78.1%

Signals

50-day / 200-day average20.55 / 16.17
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.54

Technical summary

DailyBearish4 bullish · 2 neutral · 10 bearish
WeeklyBullish7 bullish · 1 neutral · 4 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Vienna Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026